Feb 19, 2019 07:38AM
Dec 18, 2018 08:30AM
Dec 6, 2018 09:41AM
Dec 6, 2018 09:00AM
Nov 19, 2018 05:53PM
Nov 16, 2018 08:30AM
Oct 29, 2018 07:35AM Immune Pharma (IMNP) Highlights New Clinical Data from Positive, Proof-of-Concept Phase 2a Trial of Bertilimumab in Bullous Pemphigoid
Oct 29, 2018 07:30AM
Oct 17, 2018 09:06AM
Oct 17, 2018 09:00AM
Oct 10, 2018 04:30PM
Sep 13, 2018 07:30AM
Sep 11, 2018 07:30AM
Sep 10, 2018 07:00AM Immune Pharmaceuticals Issues Statement on Former Chief Executive Officer
Aug 20, 2018 11:41AM
Aug 20, 2018 11:34AM
Aug 2, 2018 04:05PM
Jul 30, 2018 08:05AM
Jul 30, 2018 08:00AM
Jul 26, 2018 09:15AM
Jul 26, 2018 09:15AM Immune Pharmaceuticals Receives Nasdaq Delisting Determination; Eligible to trade Over-the-Counter July 26, 2018
Jul 17, 2018 08:36AM
Jul 17, 2018 08:30AM
Jul 17, 2018 08:30AM
Jul 9, 2018 07:06AM
Jul 9, 2018 07:00AM
Jul 9, 2018 07:00AM
Jun 8, 2018 08:35AM Immune Pharma (IMNP) Receives Nasdaq Listing Determination
Jun 8, 2018 08:30AM
Jun 8, 2018 08:30AM
May 23, 2018 08:03AM
May 23, 2018 08:00AM
May 23, 2018 08:00AM
May 15, 2018 09:00AM
May 15, 2018 09:00AM Immune Pharmaceuticals Presents Updated Positive Results from Phase 2 Trial of Bertilimumab in Bullous Pemphigoid
May 15, 2018 09:00AM
May 7, 2018 08:44AM
May 7, 2018 08:30AM
May 7, 2018 08:30AM
Apr 2, 2018 05:20PM
Mar 12, 2018 08:00AM
Feb 6, 2018 08:00AM Immune Pharmaceuticals to Present at the BIO CEO & Investor Conference on February 12, 2018
Jan 26, 2018 08:00AM
Jan 23, 2018 09:00AM
Jan 10, 2018 11:15AM
Jan 4, 2018 09:00AM
Dec 11, 2017 11:00AM
Nov 15, 2017 08:34AM
Oct 31, 2017 07:45AM Consolidated Research: 2018 Summary Expectations for Columbia Property Trust, Dr Pepper Snapple, Immune Pharmaceuticals, Air Products and Chemicals, Box, and ACADIA Pharma – Fundamental Analysis, Ke
Oct 23, 2017 12:09PM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All